Home Cart Sign in  
Chemical Structure| 95635-56-6 Chemical Structure| 95635-56-6

Structure of Ranolazine 2HCl
CAS No.: 95635-56-6

Chemical Structure| 95635-56-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ranolazine 2HCl is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

Synonyms: CVT 303 dihydrochloride; RS 43285; Ranolazine(hydrochloride)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ranolazine 2HCl

CAS No. :95635-56-6
Formula : C24H35Cl2N3O4
M.W : 500.46
SMILES Code : O=C(NC1=C(C)C=CC=C1C)CN2CCN(CC(O)COC3=CC=CC=C3OC)CC2.[H]Cl.[H]Cl
Synonyms :
CVT 303 dihydrochloride; RS 43285; Ranolazine(hydrochloride)
MDL No. :MFCD03788770
InChI Key :RJNSNFZXAZXOFX-UHFFFAOYSA-N
Pubchem ID :71279

Safety of Ranolazine 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Calcium Channel

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 10 µmol/L Empagliflozin significantly inhibited late-INa in R1623Q and ΔKPQ mutant Nav1.5 channels Circulation. 2021 Jun;143(22):2188-2204.
Mouse cardiomyocytes 10 µmol/L Empagliflozin significantly inhibited late-INa in cardiomyocytes from mice with heart failure, restoring it to levels similar to those in sham-operated controls Circulation. 2021 Jun;143(22):2188-2204.
WM9 cells 50 µM or 100 µM Once per week To assess the effect of Ranolazine on the development of BRAF inhibitor resistance, results showed that Ranolazine significantly reduced the establishment of acquired resistance colonies Nat Metab. 2023 Sep;5(9):1544-1562.
A375 cells 100 µM Once per week To assess the effect of Ranolazine on the development of BRAF inhibitor resistance, results showed that Ranolazine significantly reduced the establishment of acquired resistance colonies Nat Metab. 2023 Sep;5(9):1544-1562.
HEK cells (expressing NaV1.5) 50 μM 10 minutes Ranolazine blocks current at rest and inhibits the mechanical activation of NaV1.5 expressed in HEK cells. Circulation. 2012 Jun 5;125(22):2698-706.
Murine ventricular cardiac myocytes 50 μM 10 minutes Ranolazine not only blocks peak NaV current but also inhibits the response of NaV channels to mechanical stimulation by bath flow. Circulation. 2012 Jun 5;125(22):2698-706.
MDA-MB-231-Luc cells 50 μM 24 hours Inhibited Na V1.5 currents and reduced breast cancer cell invasiveness Mol Cancer. 2014 Dec 11;13:264.
Detergent extracted fiber bundles 10 μmol/L 15 minutes To evaluate the effect of Ranolazine on myofilament Ca2+ sensitivity and cross-bridge kinetics. Results showed that Ranolazine reduced maximum tension and Ca2+ sensitivity in DOCA-salt fiber bundles, restoring them to levels similar to controls. Circ Res. 2012 Mar 16;110(6):841-50.
Cardiomyocytes 10 μmol/L 10 minutes To evaluate the effect of Ranolazine on diastolic function in DOCA-salt cardiomyocytes. Results showed that Ranolazine significantly improved diastolic function, normalizing the relaxation time constant τ. Circ Res. 2012 Mar 16;110(6):841-50.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice A375 human melanoma xenograft model Intraperitoneal injection 50 mg/kg Once daily for up to 50 days To assess the effect of Ranolazine on BRAF inhibitor therapy, results showed that Ranolazine significantly reduced tumor growth and delayed the onset of resistance Nat Metab. 2023 Sep;5(9):1544-1562.
NMRI nude mice Immunodepressed mice model Intraperitoneal injection 50 mg/kg/day 5 days per week for 8 weeks Significantly reduced lung colonization by Na V1.5-expressing human breast cancer cells Mol Cancer. 2014 Dec 11;13:264.
Mice SGK1-CA transgenic mice Subcutaneous implantation 140 mg/pellet (two 14-day release pellets) 7 days To study the effect of ranolazine on QT interval, cardiac function, and arrhythmias in SGK1-CA mice Circulation. 2012 Oct 30;126(18):2208-19.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.00mL

0.40mL

0.20mL

9.99mL

2.00mL

1.00mL

19.98mL

4.00mL

2.00mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories